Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

AstraZeneca · Phase 2 · Completed · Enrollment 177

NCT00392925

ArmPopulationDoseWeeksEstimandWeight change
Placebo and MetreleptinObesity or overweightn/rn/rn/rn/r
Pramlintide Acetate and PlaceboObesity or overweightn/rn/rn/rn/r
Pramlintide Acetate and MetreleptinObesity or overweightn/rn/rn/rn/r
Lead-In PeriodObesity or overweightn/rn/rn/rn/r